PCE and CPE’s February 2023 webinar report examines opportunities and challenges of the EU HTA Regulation with EC, MEPs, ESMO, EFPIA, and patient advocates. Read More
39 stakeholders call on EU HTA Coordination Group to adopt fit-for-purpose JCA methodology for ATMPs, recognising single-arm trials and real-world evidence. Read More
CPE’s February 2025 European Parliament event report on embedding cancer health indicators in the EU Semester to tackle inequalities in cancer care across Europe. Read More
CPE supports the ASCERTAIN project survey on Cost-Effectiveness Thresholds in healthcare. Share your views to help shape equitable HTA tools across Europe. Read More
CPE and CECOG call on EU institutions to pilot cancer indicators in the European Semester and develop a Cancer Inequalities Dashboard to reduce disparities in care. Read More
CPE’s ESMO 2024 advisory board report examines barriers to shared decision-making in breast cancer care, with recommendations for clinicians and patient organisations. Read More
CPE’s 2025 Position Paper calls on EU trilogue negotiators to adopt a broad, flexible, patient-centred definition of Unmet Medical Need in pharmaceutical law reform. Read More
CPE’s European Parliament event report on ESR1 mutations and liquid biopsy in metastatic breast cancer — key findings, MEP statements, and policy recommendations. Read More